D. E. Shaw & Co., Inc. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$119,000
-95.2%
13,744
-92.1%
0.00%
-100.0%
Q4 2021$2,496,000
+1881.0%
174,795
+530.8%
0.00%
Q4 2014$126,000
-8.0%
27,708
+63.0%
0.00%
Q3 2014$137,000
-35.4%
17,003
-22.9%
0.00%
Q2 2014$212,00022,0440.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders